Follow
Fatima Valdes-Mora
Fatima Valdes-Mora
Children's Cancer Institute (Sydney, Australia)
Verified email at ccia.org.au - Homepage
Title
Cited by
Cited by
Year
Myeloid-derived suppressor cells as a therapeutic target for cancer
AMK Law, F Valdes-Mora, D Gallego-Ortega
Cells 9 (3), 561, 2020
3432020
Acetylation of H2A. Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer
F Valdés-Mora, JZ Song, AL Statham, D Strbenac, MD Robinson, SS Nair, ...
Genome research 22 (2), 307-321, 2012
2242012
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer
J Achinger-Kawecka, F Valdes-Mora, PL Luu, KA Giles, CE Caldon, W Qu, ...
Nature communications 11 (1), 320, 2020
1182020
Differential role of human choline kinase α and β enzymes in lipid metabolism: implications in cancer onset and treatment
D Gallego-Ortega, A Ramirez de Molina, MA Ramos, F Valdes-Mora, ...
PloS one 4 (11), e7819, 2009
1182009
Cdc42 is highly expressed in colorectal adenocarcinoma and downregulates ID4 through an epigenetic mechanism
T Gómez del Pulgar, F Valdés-Mora, E Bandrés, R Pérez-Palacios, ...
International journal of oncology 33 (1), 185-193, 2008
1152008
Droplet-based single cell RNAseq tools: a practical guide
R Salomon, D Kaczorowski, F Valdes-Mora, RE Nordon, A Neild, ...
Lab on a Chip 19 (10), 1706-1727, 2019
1042019
TWIST1 overexpression is associated with nodal invasion and male sex in primary colorectal cancer
F Valdés-Mora, T Gomez del Pulgar, E Bandrés, P Cejas, ...
Annals of surgical oncology 16, 78-87, 2009
1032009
ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer
M Kalyuga, D Gallego-Ortega, HJ Lee, DL Roden, MJ Cowley, CE Caldon, ...
PLoS biology 10 (12), e1001461, 2012
1022012
Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains
A Khoury, J Achinger-Kawecka, SA Bert, GC Smith, HJ French, PL Luu, ...
Nature communications 11 (1), 54, 2020
842020
Acetylated histone variant H2A. Z is involved in the activation of neo-enhancers in prostate cancer
F Valdés-Mora, CM Gould, Y Colino-Sanguino, W Qu, JZ Song, KM Taylor, ...
Nature Communications 8 (1), 1346, 2017
822017
ELF5 drives lung metastasis in luminal breast cancer through recruitment of Gr1+ CD11b+ myeloid-derived suppressor cells
D Gallego-Ortega, A Ledger, DL Roden, AMK Law, A Magenau, ...
PLoS biology 13 (12), e1002330, 2015
762015
Single-cell transcriptomics in cancer immunobiology: the future of precision oncology
F Valdes-Mora, K Handler, AMK Law, R Salomon, D Gallego-Ortega
Frontiers in immunology 9, 395459, 2018
752018
Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancer
A Stone, F Valdes-Mora, JMW Gee, L Farrow, RA McClelland, H Fiegl, ...
Plos one 7 (7), e40466, 2012
752012
Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer
C Stirzaker, JZ Song, W Ng, Q Du, NJ Armstrong, WJ Locke, AL Statham, ...
Oncogene 36 (10), 1328-1338, 2017
732017
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis
M Papanicolaou, AL Parker, M Yam, EC Filipe, SZ Wu, JL Chitty, K Wyllie, ...
Nature communications 13 (1), 4587, 2022
662022
Involvement of human choline kinase alpha and beta in carcinogenesis: a different role in lipid metabolism and biological functions
D Gallego-Ortega, TG del Pulgar, F Valdés-Mora, A Cebrián, JC Lacal
Advances in enzyme regulation 51 (1), 183-194, 2011
632011
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer
A Stone, MJ Cowley, F Valdes-Mora, RA McCloy, CM Sergio, ...
Molecular cancer therapeutics 12 (9), 1874-1885, 2013
61*2013
Prostate cancer epigenetic biomarkers: next-generation technologies
F Valdes-Mora, SJ Clark
Oncogene 34 (13), 1609-1618, 2015
592015
Lineage Specific Methylation of the Elf5 Promoter in Mammary Epithelial Cells
HJ Lee, RA Hinshelwood, T Bouras, D Gallego-Ortega, F Valdés-Mora, ...
Stem cells 29 (10), 1611-1619, 2011
582011
Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer
TG Del Pulgar, E Bandrés, C Espina, F Valdés-Mora, R Pérez-Palacios, ...
The International Journal of Biochemistry & Cell Biology 39 (12), 2289-2302, 2007
572007
The system can't perform the operation now. Try again later.
Articles 1–20